Multiregion gene-expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer
Continuous advancements in biologic drug development, supportive reimbursement frameworks, and growing investment in chronic disease management programs are further driving market growth in Germany
5 This sharp rise underscores the importance of understanding their impact on weight loss
Many individuals prefer lighter protein shakes or ready-to-drink options that feel easier to consume in smaller portions rather than large, heavy meals
6b), MB07811, a liver-targeted TR agonist could enhance insulin secretion and reduce glucose levels independent of weight loss in non-obese mice (Fig
Tirzepatide was FDA-approved for T2D in 2022, and showed impressive weight reductions in subsequent obesity trials